BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025

Core Viewpoint - BioNTech SE will announce its financial results for Q4 and full year 2024 on March 10, 2025, and will host a conference call and webcast for stakeholders to discuss these results and provide a corporate update [1]. Group 1: Financial Results Announcement - The financial results for Q4 and the full year 2024 will be disclosed on March 10, 2025 [1]. - A conference call and webcast will take place at 8:00 a.m. EDT (1:00 p.m. CET) on the same day [1]. Group 2: Accessing the Conference Call - Participants can register for the live conference call via a provided link, with dial-in numbers and a PIN sent after registration [2]. - It is recommended to register at least one day in advance for the call [2]. - The slide presentation and audio of the webcast will be accessible through a specified link [2]. Group 3: Company Overview - BioNTech is a global next-generation immunotherapy company focused on developing novel therapies for cancer and serious diseases [4]. - The company utilizes a variety of computational discovery and therapeutic drug platforms for rapid biopharmaceutical development [4]. - BioNTech's oncology product portfolio includes mRNA-based therapies, CAR T cells, protein-based therapeutics, and small molecules [4]. - The company is also developing multiple mRNA vaccine candidates for infectious diseases alongside its oncology pipeline [4]. - BioNTech has established collaborations with various global pharmaceutical companies, including Pfizer and Genentech [4].